12:00 AM
 | 
May 14, 2012
 |  BC Week In Review  |  Clinical News  |  Clinical Status

Perindopril/amlodipine: Phase III started

In late February, Xoma began the double-blind, U.S. Phase III PATH trial to compare an oral fixed-dose combination of perindopril plus amlodipine once daily for 6 weeks vs. perindopril or amlodipine alone in about 816 patients. In January, Xoma...

Read the full 175 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$30 USD
More Info >